Risk assessment for recurrent venous thrombosis
Paul A. Kyrle(Karl Landsteiner Society), Sabine Eichinger(Universitätsmedizin Greifswald), Frits R. Rosendaal(Leiden University Medical Center)
Cited by 261
Related Papers
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
|New England Journal of Medicine|2021|2.3k
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|764
Deep vein thrombosis
|The Lancet|2005|620
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH
|Journal of Thrombosis and Haemostasis|2016|582